Peripheral Arterial Disease Trial, Recruiting NCT06149650 Sponsor: Cardiovascular and Interventional Radiological Society of Europe Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06149650
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with a serious condition where severely reduced blood flow to a limb is causing significant symptoms (classified as Rutherford Category 4 or higher)
  • People who have calcified (hardened) blockages in the arteries of the upper leg, behind the knee, or lower leg that can be seen on X-ray imaging
  • People whose treatment plan includes a specific procedure using the Shockwave Medical IVL System, a device that uses sound wave energy to break up calcium in artery walls

Who may not be able to join:

  • People under 18 years of age
  • People who are unable or unwilling to provide informed consent to participate
  • People who are currently pregnant
  • People who have had a procedure performed on the same area of blood vessels within 4 weeks before the planned treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raman Uberoi, Dr, Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom

Phone: +41 79 385 16 78

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cardiovascular and Interventional Radiological Society of Europe
Registry
ClinicalTrials.gov
Start date
15 July 2024
Est. completion
15 July 2028

Where this trial is recruiting

🇦🇹 Austria 🇨🇦 Canada 🇫🇷 France 🇩🇪 Germany 🇭🇺 Hungary 🇪🇸 Spain 🇨🇭 Switzerland 🇬🇧 United Kingdom

Primary endpoints

Wound healing and freedom from amputation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov